Do children and adolescents with type 1 diabetes suffer from a lack of resources in France? Results from a benchmark study in the New Aquitaine region.


Journal

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
ISSN: 1769-664X
Titre abrégé: Arch Pediatr
Pays: France
ID NLM: 9421356

Informations de publication

Date de publication:
May 2021
Historique:
received: 27 08 2020
revised: 09 12 2020
accepted: 10 02 2021
pubmed: 22 3 2021
medline: 15 12 2021
entrez: 21 3 2021
Statut: ppublish

Résumé

A benchmark study was conducted in the southwest of France, in the New Aquitaine region, to investigate metabolic outcomes and availability of resources in pediatric diabetes units. We assessed whether the level of care was in accordance with the International Society for Pediatric and Adolescent Diabetes recommendations. Demographic and clinical data were collected, as were all HbA1c tests for the 2017 calendar year. Pediatricians specialized in diabetes care were invited to complete an online survey concerning means allocated to the management of type 1 diabetes in their centers. Sixteen centers provided data for 1277 patients and 3873 clinical visits. A total of 1115 children suffering from diabetes for more than 1 year were studied. Median HbA1c was 8% (7.4-8.6) for the whole region. Only 29.2% of children had good metabolic control in accordance with the <7.5% target. We identified slight but significant variation in glycemic control among centers (P=0.029). The use of an insulin pump varied greatly among centers but did not explain HbA1c differences. We did not identify a correlation between medical or paramedical time dedicated to the follow-up of diabetic patients and the mean HbA1c of each center. For 100 diabetic patients, follow-up was provided by 0.42 physicians (0.23-1.50), 0.15 nurses (0-0.56), 0.12 dietitians (0-0.48), and 0.07 psychologists (0-0.30). This study demonstrates a lack of human resources allocated to the management of type 1 diabetes in the region that is far below international recommendations. The proportion of children achieving the international glycemic target is low. There is a clear need to improve glycemic control in children, which will only be possible with improved professional practices, encouraged by benchmark studies, and by increasing the size of our multidisciplinary teams.

Sections du résumé

BACKGROUND BACKGROUND
A benchmark study was conducted in the southwest of France, in the New Aquitaine region, to investigate metabolic outcomes and availability of resources in pediatric diabetes units. We assessed whether the level of care was in accordance with the International Society for Pediatric and Adolescent Diabetes recommendations.
METHODS METHODS
Demographic and clinical data were collected, as were all HbA1c tests for the 2017 calendar year. Pediatricians specialized in diabetes care were invited to complete an online survey concerning means allocated to the management of type 1 diabetes in their centers.
RESULTS RESULTS
Sixteen centers provided data for 1277 patients and 3873 clinical visits. A total of 1115 children suffering from diabetes for more than 1 year were studied. Median HbA1c was 8% (7.4-8.6) for the whole region. Only 29.2% of children had good metabolic control in accordance with the <7.5% target. We identified slight but significant variation in glycemic control among centers (P=0.029). The use of an insulin pump varied greatly among centers but did not explain HbA1c differences. We did not identify a correlation between medical or paramedical time dedicated to the follow-up of diabetic patients and the mean HbA1c of each center. For 100 diabetic patients, follow-up was provided by 0.42 physicians (0.23-1.50), 0.15 nurses (0-0.56), 0.12 dietitians (0-0.48), and 0.07 psychologists (0-0.30).
CONCLUSION CONCLUSIONS
This study demonstrates a lack of human resources allocated to the management of type 1 diabetes in the region that is far below international recommendations. The proportion of children achieving the international glycemic target is low. There is a clear need to improve glycemic control in children, which will only be possible with improved professional practices, encouraged by benchmark studies, and by increasing the size of our multidisciplinary teams.

Identifiants

pubmed: 33744119
pii: S0929-693X(21)00021-X
doi: 10.1016/j.arcped.2021.02.007
pii:
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

301-306

Informations de copyright

Copyright © 2021. Published by Elsevier Masson SAS.

Auteurs

M-N Campas-Lebecque (MN)

Unité d'endocrinologie et diabétologie pédiatrique, CHU de Bordeaux, place Amélie Rabat Léon, 33076 Bordeaux, France. Electronic address: marie_neige.campas@yahoo.fr.

S Pochelu (S)

Unité d'endocrinologie et diabétologie pédiatrique, CHU de Bordeaux, place Amélie Rabat Léon, 33076 Bordeaux, France.

V Vautier (V)

Unité d'endocrinologie et diabétologie pédiatrique, CHU de Bordeaux, place Amélie Rabat Léon, 33076 Bordeaux, France.

N Bacheré (N)

Unité de pédiatrie, CH Layné, 40024 Mont De Marsan, France.

C Beau (C)

Unité de pédiatrie, CH Libourne, 112, rue de la Marne, 33505 Libourne, France.

M Benoit (M)

Unité de pédiatrie, CH de Saintonge, 11, boulevard Ambroise-Paré, 17108 Saintes, France.

B Cammas (B)

22, rue Guillemin, 33300 Bordeaux, France.

M Carré (M)

Unité de pédiatrie, CH Côte-Basque, 13, avenue Jacques-Loeb, BP, 64109 Bayonne, France.

J Chevrel (J)

Unité de pédiatrie, CH Côte-d'argent, boulevard Yves-Du-Manoir, 40107 Dax, France.

F Compain (F)

Unité de pédiatrie, CHU de Poitiers, 2, rue de la Milétrie, 86000 Poitiers, France.

A Fargeot-Espaliat (A)

Unité de pédiatrie, CH de Brive, 1, boulevard du Dr-Verlhac, 19312 Brive La Gaillarde, France.

M Franc (M)

Unité de pédiatrie, CH Agen-Nérac, 47923 Agen, France.

A Galtier (A)

Unité de pédiatrie, CH Samuel Pozzi, 9, boulevard Pr-Calmette, 24100 Bergerac, France.

C Gambert (C)

Unité de pédiatrie, CHU de Poitiers, 2, rue de la Milétrie, 86000 Poitiers, France.

A Lacoste (A)

Polyclinique Bordeaux Rive Droite, 24, rue des Cavailles, 33310 Lormont, France.

A Lienhardt (A)

Unité d'endocrinologie et diabétologie pédiatrique, CHU Dupuytren, 8, avenue Larrey, 87042 Limoges, France.

L Martineau (L)

Unité de pédiatrie, CH d'Angoulême, rond point de Girac, 16959 Angoulême, France.

L Oilleau (L)

Unité de pédiatrie, CH de Pau, 4, boulevard Hauterive, 64046 Pau, France.

M Percot-Blondy (M)

Unité de pédiatrie, CH de Périgueux, 80, avenue Pompidou, 24019 Périgueux, France.

A Tamboura (A)

Unité de pédiatrie, CH de Rochefort, 1, avenue de Béligon, 17301 Rochefort, France.

A Valade (A)

Unité de pédiatrie, CH Côte-Basque, 13, avenue Jacques-Loeb, BP, 64109 Bayonne, France.

P Barat (P)

Unité d'endocrinologie et diabétologie pédiatrique, CHU de Bordeaux, place Amélie Rabat Léon, 33076 Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH